James Sapirstein, a reporting person for ZyVersa Therapeutics, Inc. [ZVSA], engaged in a transaction involving the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. Consequently, the number of shares held by Sapirstein after the transaction remains unknown. This information is critical for investors to understand the potential impact on their investment and the confidence level of insiders in the company's performance.

James Sapirstein, a reporting person for ZyVersa Therapeutics, Inc. [ZVSA], engaged in a transaction involving the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. Consequently, the number of shares held by Sapirstein after the transaction remains unknown. This information is critical for investors to understand the potential impact on their investment and the confidence level of insiders in the company's performance.